Traditional Chinese medicine regulating body and preventing disease based on TCM constitution: A demonstration study of Covid-19 prevention for key populations (Anti-epidemic Special No.: 2022011)

Traditional Chinese medicine regulating body and preventing disease based on TCM constitution: A demonstration study of Covid-19 prevention for key populations

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006544

Enrollment

Unknown

Registered

2022-08-29

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biased constitution (Qi deficiency and phlegm-dampness)

Interventions

The herbal tea control group with qi deficiency constitution:Chinese herbal tea, five days one week

The experimental group with qi deficiency constitution:sachet and Chinese herbal tea

The blank control group with qi deficiency constitution:No intervention

The sachet control group with phlegm-dampness constitution:Wear Chinese herbal sachet and smell

The blank control group with phlegm-dampness constitution:No intervention

The experimental group with phlegm-dampness constitution:sachet and Chinese herbal tea

The herbal tea control group with phlegm-dampness constitutionp:Chinese herbal tea, five days one week

The sachet control group with qi deficiency constitution:Wear Chinese herbal sachet

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Key populations of Shenzhen's epidemic prevention (such as transportation personnel, Big supermarkets, and medical institution staff), who have a negative COVID-19 nucleic acid test and have completed the whole course of the Covid-19 vaccination; (2) Men or women aged 18-60; (3) Those who have a phlegm-dampness constitution or a Qi-deficiency constitution after being identified by a professional TCM doctor.

Exclusion criteria

Exclusion criteria: (1) Severe systemic diseases (malignant tumors, autoimmune diseases, liver and kidney diseases) or surgical operations (splenectomy, organ transplantation); (2) Pregnant or lactating women; (3) Participate in other clinical trials within three months; ?Allergic to the research drug; ? With other constitutions; ? Other conditions judged by the investigators.

Design outcomes

Primary

Measure	Time frame
Immune Function(IgG\IGA\IFN-a/ß);TCM constitution score;	—

Secondary

Measure	Time frame
The ten symptoms of Covid-19;36-item Short Form Health Survy;Safety(adverse events, blood routine, urine routine, fecal routine,Liver and kidney function, ECG);	—

Countries

China

Contacts

Public ContactHu Shi-ping

Beijing University of Chinese Medicine Shenzhen Hospital(Longgang)

hushiping21@163.com19866151577

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026